|Denaro||69,74 x 800|
|Lettera||69,80 x 1100|
|Min-Max giorno||68,79 - 70,43|
|Intervallo di 52 settimane||33,65 - 70,43|
|Beta (5 anni mensile)||1,37|
|Rapporto PE (ttm)||7,80|
|Prossima data utili||28 ott 2021 - 01 nov 2021|
|Rendimento e dividendo (forward)||0,58 (0,85%)|
|Data ex dividendo||13 ago 2021|
|Stima target 1A||77,42|
SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that Founder and CEO Mark Blumling will participate in a panel session during the Milken Institute Global Conference on Wednesday, October 20, 2021 at 8:30 a.m. PT in Los Angeles, CA. The panel is titled: The Impact of Investing in Health Equity in Biomedical Research. It will focus on how investing in the value of health e
U.S.-based investment firm KKR & Co reported better-than-expected earnings in the first quarter of 2021, largely driven by a higher level of carried interest and an increase in transaction and management fees.
U.S.-based investment firm KKR & Co’s shares hit a fresh high on Monday after the company reported better-than-expected earnings in the fourth quarter of 2020, largely driven by a higher level of carried interest and an increase in transaction and management fees.